M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma
ConclusionCompared with M1, M2 macrophages can inhibit the anti-tumor effect of Lenvatinib on cholangiocarcinoma through immune regulation, which may be related to the tumor angiogenesis factor effect of M2 macrophage.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma